Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 18 of the 20 references it cites were found in a registry or an index; 20 of the 35 sources its claims cite were checked for support.

HRT in Women Undergoing Pelvic Clearance for Endometriosis—A Case Report and a National Survey

Open access
Amer, Saad, Bazmi, Subul · 2023 · Journal of Clinical Medicine

Abstract

The optimal hormone replacement therapy (HRT) in women who have undergone pelvic clearance for endometriosis remains uncertain with insufficient evidence. The purpose of this case report and the national survey was to highlight the potential HRT-related risks and to establish current HRT practice in this group of women. The case was a 45-year-old woman presenting with recurrence of severe chronic pelvic pain while on oestrogen-only HRT (EO-HRT) for five years after subtotal hysterectomy and bilateral oophorectomy for severe endometriosis. MRI revealed multiple peri-cervical endometriomas and severe right hydroureter/hydronephrosis with complete right renal parenchymal loss. The survey was a 21-item questionnaire administered electronically using SurveyMonkey. It was reviewed and approved by British Menopause Society and British Society of Gynaecological endoscopy and was sent to their members as well as NHS Gynaecologists. A total of 216 physicians responded including 120 (55.6%) Gynaecology Consultants and 96 (44.4%) GPs/Nurses in Menopause clinics. Overall, 68.6% of responders prescribe combined HRT (C-HRT), 11.1% tibolone, 13.0% EO-HRT and 7.8% varied HRT. Fifty-one percent prescribe the progestogen component of C-HRT indefinitely, 22% for 3–6 months and 27% for varied durations. In conclusion, this study highlights the real risk of endometriosis recurrence in EO-HRT users after pelvic clearance for endometriosis. The survey revealed that only two thirds of Gynecologists/Menopause practitioners prescribe combined HRT in this group of women.

Overview

CoChat Summary

TL;DR

This paper combines a case report and a UK national survey on hormone replacement therapy (HRT) after pelvic clearance for endometriosis. It reports severe endometriosis recurrence with oestrogen-only HRT and wide variation in clinician practice, with only about two-thirds prescribing combined HRT.

Key findings

  • In the case report, a 45-year-old woman developed recurrence of severe chronic pelvic pain while on high-dose oestrogen-only HRT (estradiol valerate 3 mg/day) five years after subtotal hysterectomy and bilateral salpingo-oophorectomy for severe endometriosis; MRI showed multiple peri-cervical endometriomas (largest 3 cm), severe right hydroureter/hydronephrosis, and complete right renal parenchymal loss. After trachelectomy and excision of endometriomas, she reported complete disappearance of pelvic pain six weeks after surgery.
  • In the national survey, 216 clinicians responded (70% completion rate). Overall, 68.6% prescribe combined HRT, 13.0% oestrogen-only HRT, 11.1% Tibolone, and 7.8% varied HRT.
  • Most responders (63.4%) start HRT immediately after surgery; 60.9% would give the progestogen component indefinitely, while 19.3% would give it for 1–2 years and 8.5% for 3–6 months.
  • Most responders offer combined HRT to prevent recurrence of endometriosis (79%), de novo endometriosis (39%), or malignant transformation of residual endometriosis (42%); 63% prescribe combined HRT based on anecdotal evidence and personal experience, and 66% indicated a lack of clear guidance.

Methods

  • Design: a case report plus a cross-sectional national survey of clinicians managing surgical menopause after pelvic clearance for endometriosis, defined as total hysterectomy and bilateral salpingo-oophorectomy with excision of endometriosis.
  • Survey: a 21-item electronic questionnaire administered via SurveyMonkey, reviewed and approved by representatives of the British Menopause Society and British Society of Gynaecological Endoscopy, and sent to their members and other NHS gynaecologists; 216 responses were analysed after excluding one irrelevant responder.
  • Analysis: descriptive percentages are reported, with comparison between responder grades using a Q-square test; a statistically significant difference (<0.05) was found between gynaecology consultants and GP/CNS/APN in prescribing Tibolone (25.0% versus 2.3%).

Limitations

  • The paper states that the survey relied on self-reporting of practice with no independent verification of actual management, and that presenting a list of “ideal” options may have resulted in respondent bias.
  • The paper states that responder numbers in each group were not as large as hoped, though they were considered a very good representative sample, and the 70% completion rate was considered excellent for this type of survey.
  • Evident from the text: the case report is a single patient, which limits generalizability; the paper also notes limited evidence and calls for adequately powered prospective studies.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/jcm12010336

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Pelvic MRI image with a lateral view showing multiple endometriomas around the cervical stump with extensive adhesions to the sigmoid colon.
Figure 1 Pelvic MRI image with a lateral view showing multiple endometriomas around the cervical stump with extensive adhesions to the sigmoid colon.CC BY · PubMed Central
Figure 2 Laparoscopic images of extensive adhesiolysis and excision of peri-cervical endometriomas and cervical stump (a) Pelvic survey showing complete obliteration of pelvis with sigmoid adhesions; (b) Peri-cervical endometriomas revealed after complete mobilization of bowel; (c) Cervical stump completely dissected from surrounding adhesions and bowel; (d) Colpotomy with complete excision of cervix with the attached endometriomas.
Figure 2 Laparoscopic images of extensive adhesiolysis and excision of peri-cervical endometriomas and cervical stump (a) Pelvic survey showing complete obliteration of pelvis with sigmoid adhesions; (b) Peri-cervical endometriomas revealed after complete mobilization of bowel; (c) Cervical stump completely dissected from surrounding adhesions and bowel; (d) Colpotomy with complete excision of cervix with the attached endometriomas.CC BY · PubMed Central
Figure 3 Grades and experiences of responders to the Survey (a) Percentages of different physicians/practitioners who responded to the survey; (b) Percentages of responders with different years of experience in managing women with surgical menopause after pelvic clearance for endometriosis. Abbreviations: GP, General Practitioner; CNS, Clinical Nurse Specialist; APN, Advanced Nurse Practitioner.
Figure 3 Grades and experiences of responders to the Survey (a) Percentages of different physicians/practitioners who responded to the survey; (b) Percentages of responders with different years of experience in managing women with surgical menopause after pelvic clearance for endometriosis. Abbreviations: GP, General Practitioner; CNS, Clinical Nurse Specialist; APN, Advanced Nurse Practitioner.CC BY · PubMed Central
Figure 4 HRT and women’s age: the percentages of responders prescribing HRT to different age groups after surgical menopause in women with endometriosis.
Figure 4 HRT and women’s age: the percentages of responders prescribing HRT to different age groups after surgical menopause in women with endometriosis.CC BY · PubMed Central
Figure 5 Type of HRT prescribed (a) Overall percentages of responders prescribing different types of HRT; (b) Percentages of responders of different grades prescribing different types of HRT; (c) Percentages of responders prscribing combined HRT according to endometriosis severity or completeness of excision; (d) Percentages of responders prescribing oestrogen only HRT according to endometriosis severity or completeness of excision. Abbreviations: Gynae, Gynaecology; Endo, Endometriosis Specialist; Cons, Consultant; Meno, Menopause specialist; GP, General Practitioners; CNS, Clinical Nurse Specialist; APN, Advanced Nurse Practitioner.
Figure 5 Type of HRT prescribed (a) Overall percentages of responders prescribing different types of HRT; (b) Percentages of responders of different grades prescribing different types of HRT; (c) Percentages of responders prscribing combined HRT according to endometriosis severity or completeness of excision; (d) Percentages of responders prescribing oestrogen only HRT according to endometriosis severity or completeness of excision. Abbreviations: Gynae, Gynaecology; Endo, Endometriosis Specialist; Cons, Consultant; Meno, Menopause specialist; GP, General Practitioners; CNS, Clinical Nurse Specialist; APN, Advanced Nurse Practitioner.CC BY · PubMed Central

Verification

Claims the paper makes

17 Valid · 2 Not valid · 7 Not checked · 68 Own results and interpretations

32 more claims · 2 with their cited sources checked

Create a free account to see all 94 claims and to verify the 1 reference still open.

See all claims — free account
  • Probably not a substantial claim. 22
  • It may state two separate claims as one. 44
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 20 references

Cited by

See all 11

Metadata

Authors
Amer, S., & Bazmi, S.
Affiliations
  • University of Nottingham (GB)
  • University Hospitals of Derby and Burton NHS Foundation Trust (GB)
Corresponding author
Amer, Saad
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2023-01-01
Volume
12
Issue
1
Pages
336
ISSN
2077-0383 (ISSN-L)
OpenAlex
W4313472829
Cited by
11
References
20
Citations by year
2026: 3 · 2025: 3 · 2024: 3 · 2023: 2
FWCI
2.64
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Repository@Nottingham (University of Nottingham) (publishedVersion, other-oa)
  • Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Keywords
hormone replacement therapy, endometriosis, endometriosis recurrence, chronic pelvic pain, subtotal hysterectomy, bilateral oophorectomy, endometrioma, hydronephrosis, prescribing patterns, tibolone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-02, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-02 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HRT in Women Undergoing Pelvic Clearance for Endometriosis—A Case Report and a National Survey. https://app.cochat.ai/papers/10.3390/jcm12010336
The paper
Amer, S., & Bazmi, S. (2023). HRT in Women Undergoing Pelvic Clearance for Endometriosis—A Case Report and a National Survey. Journal of Clinical Medicine. https://doi.org/10.3390/jcm12010336

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.